Loading
Find Us on Facebook Follow Us on Twitter Bookmark & Share Subscribe to Feed
Wanna join our 6011 other users? | Register
Menu 

biotechdaily: Drug Discovery

    BIOtechNow: Health

    CNET: Health Tech

    DailyMed: Drug Label Updates

    Medical News Today: Clinical / Trials

    Pharmaceutical Technology

    Janine Just, Inc.
    Janine Just, Inc.
    Janine Just, Inc.
    Janine Just, Inc.

    PharmaTimes: World News

    • newCOPD survey reveals gaps in care
      A survey of 500 people across Britain diagnosed with chronic obstructive pulmonary disease (COPD) has revealed that almost a third (31 percent) feel their treatment is not adequately controlling their condition.
      - 10 hours ago, 17 Nov 17, 6:39am -
    • newFDA widens scope of Pfizer’s Sutent in kidney cancer
      The US Food and Drug Administration has cleared Pfizer’s Sutent for adjuvant treatment of adults at a high risk of their kidney cancer returning after a kidney has been removed.
      - 10 hours ago, 17 Nov 17, 6:32am -
    • newRoche bags new approvals for Hemlibra, Gazyva
      US regulators have issued a green light for Roche’s haemophilia A therapy Hemlibra and also expanded the scope of Gazyva to include untreated advanced follicular lymphoma.
      - 10 hours ago, 17 Nov 17, 6:29am -
    • newNew data show public support for tax rises to fund NHS
      Fifty-eight percent of adults talking part in a YouGov poll have backed a one percent rise in National Insurance tax to increase public spend on the NHS.
      - 10 hours ago, 17 Nov 17, 6:23am -
    • newFill out the MCQ today
      PharmaTimes Clinical Researcher of the Year - The Americas is now open for entry.
      - 11 hours ago, 17 Nov 17, 4:50am -
    • newInternational Clinical Researcher of the Year - Register your details to start Stage 1
      The PharmaTimes International Clinical Researcher of the year competition is now open for entry
      - 12 hours ago, 17 Nov 17, 4:22am -
    • EU advisors back expanding use of Adcetris
      Takeda’s Adcetris could soon be on the market in Europe as a second-line treatment for adults with CD30-positive cutaneous T-cell lymphoma (CTCL) after regulatory advisors backed expanding the drug’s scope.
      - 1 day ago, 16 Nov 17, 5:47am -
    • Green light for minimum alcohol pricing in Scotland
      Health officials have welcomed a decision by the Supreme Court that allows the introduction of minimum unit pricing in Scotland, which sets a minimum unit price of 50 pence per unit for alcohol.
      - 1 day ago, 16 Nov 17, 5:43am -
    • GSK, Innoviva’s Trelegy Ellipta cleared for COPD
      GlaxoSmithKline and Innoviva have won European approval for the novel triple therapy inhaler Trelegy Ellipta, offering a new treatment option for patients with Chronic Obstructive Pulmonary Disorder (COPD).
      - 1 day ago, 16 Nov 17, 5:41am -
    • NICE waves through breast cancer drugs following price deals
      The National Institute for Health and Care Excellence is backing routine NHS funding for Pfizer's Ibrance and Novartis' Kisqali to treat certain forms of breast cancer, after the firms agreed to provide them at a reduced price under the new process f…
      - 1 day ago, 16 Nov 17, 5:36am -

    Scientific American: Pharmaceuticals

      Emergency Comeback

      About PopMuse

      A curated aggregation of musings from across the land and of different subject matters for the scanoholics.